Skip to main content Skip to main content
Go to homepage

Oxybutynin for Neurogenic Bladder

Safety and effectiveness of oxybutynin in children (6-16 years) with neurogenic bladder

Who May Qualify?:

Patients 6-16 years old with neurogenic detrusor overactivity

Who Does Not Qualify:

Patients who are pregnant, involved in other investigational studies or have certain medical conditions

Study Status:
Full IRB Study Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Subjects
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

Lead Investigator
Daniel McMahon, MD

Director, Pediatric Urology; Pediatric Urologist
Pediatric UrologyKidney Stone Clinic

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.